Q3 2021

Filed Nov 12, 2021 · 10-Q · 43 days after period end · 0001104659-21-138123

Q3 2021 · 10-Q

Revenue—

Net Income

$5.57M

no prior Q3 2020 on file

EPS, diluted—

Operating Income-$2,986,458—

Operating Cash Flowderived-$701,352—

Same quarter

no prior Q3 2020 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2021 · filed Nov 12, 2021 · 43 d after period end

Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR